These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 3044912)

  • 41. Effect of omeprazole on the course of associated esophagitis and laryngitis.
    Jaspersen D; Weber R; Hammar CH; Draf W
    J Gastroenterol; 1996 Dec; 31(6):765-7. PubMed ID: 9027637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
    Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
    Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Australian clinical trials of omeprazole in the management of reflux oesophagitis.
    Dent J
    Digestion; 1990; 47 Suppl 1():69-71. PubMed ID: 2093019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
    Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
    Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis.
    Schmitt C; Lightdale CJ; Hwang C; Hamelin B
    Dig Dis Sci; 2006 May; 51(5):844-50. PubMed ID: 16642422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
    Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
    Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
    Breen KJ; Desmond PV; Whelan G
    Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.
    Tytgat GN; Anker Hansen OJ; Carling L; de Groot GH; Geldof H; Glise H; Efskind P; Elsborg L; Karvonen AL; Ohlin B
    Scand J Gastroenterol; 1992; 27(3):175-83. PubMed ID: 1502478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.
    Chen CY; Lu CL; Luo JC; Chang FY; Lee SD; Lai YL
    World J Gastroenterol; 2005 May; 11(20):3112-7. PubMed ID: 15918199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High rate of clinical and endoscopic relapse after healing of erosive peptic esophagitis in children and adolescents.
    Yamamoto E; Brito HS; Ogata SK; Machado RS; Kawakami E
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):594-9. PubMed ID: 25023576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Omeprazole: therapy of choice in intellectually disabled children.
    Böhmer CJ; Niezen-de Boer RC; Klinkenberg-Knol EC; Meuwissen SG
    Arch Pediatr Adolesc Med; 1998 Nov; 152(11):1113-8. PubMed ID: 9811290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis.
    Zendehdel N; Biramijamal F; Hossein-Nezhad A; Zendehdel N; Sarie H; Doughaiemoghaddam M; Pourshams A
    Arch Iran Med; 2010 Sep; 13(5):406-12. PubMed ID: 20804307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized comparative study of omeprazole and famotidine in reflux esophagitis.
    Kawano S; Murata H; Tsuji S; Kubo M; Tatsuta M; Iishi H; Kanda T; Sato T; Yoshihara H; Masuda E; Noguchi M; Kashio S; Ikeda M; Kaneko A
    J Gastroenterol Hepatol; 2002 Sep; 17(9):955-9. PubMed ID: 12167115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.